Malta - English - Malta Medicines Authority

endo ventures limited first floor, minerva house, simmonscourt road, ballsbridge, dublin 4, ireland - zonisamide - hard capsule - zonisamide 100 mg - antiepileptics

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide capsules usp are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. zonisamide capsules are contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. the abuse and dependence potential of zonisamide has not been evaluated in human studies (see warnings, cognitive/neuropsychiatric adverse events  subsection). in a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. monkeys did not self-administer zonisamide in a standard reinforcing paradigm. rats exposed to zonisamide did not exhibit signs of physical dependence of the cns-depressant type. rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-cns depressant type.

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - zonisamide - capsule, hard - 25 milligram(s) - other antiepileptics; zonisamide

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - zonisamide - capsule, hard - 50 milligram(s) - other antiepileptics; zonisamide

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - zonisamide - capsule, hard - 100 milligram(s) - other antiepileptics; zonisamide

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - zonisamide - capsule - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - zonisamide - capsule - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - zonisamide - capsule - 100mg

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide is indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. zonisamide is contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. the abuse and dependence potential of zonisamide has not been evaluated in human studies (see warnings, cognitive/neuropsychiatric adverse events subsection). in a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. monkeys did not self-administer zonisamide in a standard reinforcing paradigm. rats exposed to zonisamide did not exhibit signs of physical dependence of the cns-depressant type. rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-cns depressant type.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - zonisamide (unii: 459384h98v) (zonisamide - unii:459384h98v) - zonisamide is indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. zonisamide is contraindicated in patients who have demonstrated hypersensitivity to sulfonamides or zonisamide. the abuse and dependence potential of zonisamide has not been evaluated in human studies (see warnings, cognitive/neuropsychiatric adverse events subsection). in a series of animal studies, zonisamide did not demonstrate abuse liability and dependence potential. monkeys did not self-administer zonisamide in a standard reinforcing paradigm. rats exposed to zonisamide did not exhibit signs of physical dependence of the cns-depressant type. rats did not generalize the effects of diazepam to zonisamide in a standard discrimination paradigm after training, suggesting that zonisamide does not have abuse potential of the benzodiazepine-cns depressant type.